2Wk·

Oscar Health - Preliminary Q2 results published and full-year guidance revised

$OSCR


The company expects an operating loss of USD 230 million in the second quarter and an operating loss of USD 200-300 million for the year as a whole.

Revenue for 2025 is now estimated at USD 12.0-12.2 billion

Medical loss ratio increases to 86-87% due to continued high risk assessments and high utilization. Adjusted EBITDA loss is expected to be approximately USD 120 million lower than the operating loss. The full report will be published pre-market on August 6


https://www.tradingview.com/news/DJN_DN20250722001515:0/


https://www.businesswire.com/news/home/20250722772545/en/Oscar-Health-Announces-Preliminary-Financial-Results-for-Second-Quarter-2025-and-Revises-2025-Guidance

attachment
6
6 Comments

profile image
And is that better or worse than expected?
1
profile image
@Multibagger due to the headwind better than expected, Wall Street is still undecided, from -8% to + 8% and now pre-market at +3% leveled off, let's wait for the opening of Wall Street and the next few weeks, I remain invested in any case .
1
profile image
@BamBamInvest Me too. Maybe I'll add a little more
1
profile image
@Multibagger certainly not a bad idea, I'm just slowly running out of capital . First of all, $UNH has to deliver 😂
1
profile image
@BamBamInvest I have this problem all the time with my small portfolio volume. $UNH I will use derivatives.
1
profile image
@Multibagger I think the sentiment is already so negative, the management knows that, there must be a positive outcry here and they had already suspended the guidance.
Join the conversation